Table 1 The clinical features of all participates in this study
Number | Sex | Age | Smoke history | TNM | Stage |
|---|---|---|---|---|---|
LA1 | Female | 75 | No | T1bN0M0 | IA2 |
LA2 | Male | 61 | Yes | T1bN0M0 | IA2 |
LA3 | Female | 37 | No | T1aN0M0 | IA1 |
LA4 | Male | 63 | Yes | T1cN0M0 | IA3 |
LA5 | Female | 62 | No | T1bN0M0 | IA2 |
LA6 | Male | 61 | Yes | T1c N0M0 | IA3 |
LA7 | Female | 57 | No | T2aN0M0 | IB |
LA8 | Female | 51 | No | T1bN0M0 | IA2 |
LA9 | Male | 51 | No | T1bN0M0 | IA2 |
LA10 | Female | 46 | No | T1b/2aN0M0 | IA2/ |
LA11 | Female | 49 | No | T1cN0M0 | IA3 |
LA12 | Female | 42 | No | T1bN0M0 | IA2 |
LA13 | Female | 60 | No | T1aN0M0 | IA1 |
LA14 | Female | 57 | No | T2aN0M0 | IB |
LA15 | Male | 70 | Yes | T1bN0M0 | IA2 |
LA16 | Male | 82 | No | T2aN0M0 | IB |
LA17 | Female | 65 | No | T1bN0M0 | IA2 |
LA18 | Female | 59 | No | T1bN0M0 | IA2 |
LA19 | Female | 63 | No | T2aN0M0 | IB |
LA20 | Female | 45 | No | PT1bN0M0 | IA2 |
Number | Sex | Age |
|---|---|---|
NL1 | Female | 31 |
NL2 | Female | 71 |
NL3 | Female | 40 |
NL4 | Female | 41 |
NL5 | Female | 41 |
NL6 | Female | 40 |
NL7 | Male | 41 |
NL8 | Male | 50 |
NL9 | Female | 29 |
NL10 | Female | 58 |
NL11 | Male | 31 |
NL12 | Female | 49 |
NL13 | Female | 48 |
NL14 | Male | 45 |
NL15 | Male | 51 |
NL16 | Male | 49 |
NL17 | Female | 38 |
NL18 | Female | 71 |
NL19 | Female | 47 |
NL20 | Male | 31 |